President Trump signed an executive order to lower prescription drug prices in the United States[1][2]. The goal is to equalize prices to the level of the lowest prices in other developed countries, where the US often pays up to three times[1]. Trump said it was one of the most important executive orders against the pharmaceutical lobby[1][2]. Prices are expected to drop by 59 to 90 percent, with non-EU countries expected to pay more or face tariffs[2]. Nine major pharmaceutical companies agreed to discounts of up to 90 percent compared to list prices[4]. Pfizer was the first company to agree to the terms, offering drugs with an average savings of 50 percent through the TrumpRx website without intermediaries[3]. The order also covers drugs outside the Medicare and Medicaid programs[1]. Trump called on 17 pharmaceutical companies to take immediate steps to lower prices[5].